GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament

Table 2

The descriptive statistical analysis of the E. faecalis count before (CFU-1) and after (CFU-2) the application of the medicaments.

Bacterial count groups	CFU-1; Mean ± SD	CFU-2; Mean ± SD
Group I Siwak	48.9 ± 53.7  10^4	0.0250 ± 0.1  10^4
Group II Ca(OH)2 (+ve control)	51.6 ± 68.4  10^4	0.07 ± 0.25  10^4
Group III Saline (−ve control)	56.3 ± 59  10^4	50 ± 115  10^4